Adene Sanchez | E+ | Getty Images Company: Exelixis (EXEL) Business: Exelixis, an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. They have produced four marketed pharmaceutical products, including their flagship molecule, cabozantinib. Stock Market Value: $6.3B ($19.46 per share) Activist: Farallon Capital
0 Comments
Zamrznutitonovi | Istock | Getty Images New government inflation data shows inflation is cooling — and that could point to a lower cost-of-living adjustment, or COLA, for Social Security beneficiaries next year. The Consumer Price Index for all Urban Consumers, or CPI-U, rose 5% from a year ago and 0.1% in March, according to data
0 Comments
Ben Rains dives into where the stock market stands as we kick off the busy stretch of first quarter earnings season. The episode then explores two giants of key industries—Taiwan Semiconductor (TSM) and Union Pacific (UNP)—that are sitting at beaten-down levels heading into earnings that might make them attractive to long-term investors. (0:30) – Stock
0 Comments
Homes in Centreville, Maryland, US, on Tuesday, April 4, 2023.  Nathan Howard | Bloomberg | Getty Images Today’s homebuyers are exceptionally sensitive to mortgage rates with house prices so high — and they’ve found their tipping point. After years of government intervention following the great recession and the first years of the Covid-19 pandemic that
0 Comments